Menu
Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13
Original Research
Effect of background long-acting beta2-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 6,595 | Dovepress* | 6,129+ | 1,340 | 7,469 | |
| PubMed Central* | 466 | 208 | 674 | ||
| Totals | 6,595 | 1,548 | 8,143 | ||
| *Since 19 September 2018 | |||||
View citations on PubMed Central and Google Scholar